Australian Institute of Health and Welfare (2022) Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data, AIHW, Australian Government, accessed 01 November 2024.
Australian Institute of Health and Welfare. (2022). Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data. Retrieved from https://www.aihw.gov.au/reports/health-care-quality-performance/impacts-of-covid19-mbs-pbs-quarterly-data
Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data. Australian Institute of Health and Welfare, 18 February 2022, https://www.aihw.gov.au/reports/health-care-quality-performance/impacts-of-covid19-mbs-pbs-quarterly-data
Australian Institute of Health and Welfare. Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data [Internet]. Canberra: Australian Institute of Health and Welfare, 2022 [cited 2024 Nov. 1]. Available from: https://www.aihw.gov.au/reports/health-care-quality-performance/impacts-of-covid19-mbs-pbs-quarterly-data
Australian Institute of Health and Welfare (AIHW) 2022, Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data, viewed 1 November 2024, https://www.aihw.gov.au/reports/health-care-quality-performance/impacts-of-covid19-mbs-pbs-quarterly-data
PDF | 946kB
Amendments
8 June 2021
